Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
This study has been terminated.
Study NCT00585845
Information provided by Anza Therapeutics, Inc.
First Received: December 22, 2007
Last Updated: February 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
